FJ Investments’s AstraZeneca AZN Stock Holding History

FJ Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,812	Closed	-$1.46M	–	47
2023 Q4	$1.46M	Buy	+10,812	New	+$1.41M	0.07%	144

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FJ Investments's AZN Position: Q1 2024 in Review

FJ Investments sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 10,812 shares — an estimated $1.46M sold.

FJ Investments first reported a position in AZN in Q4 2023 and held it in 1 quarter. The position peaked at $1.46M in Q4 2023. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

FJ Investments reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
FJ Investments sold 10,812 AstraZeneca shares in Q1 2024, an estimated $1.46M.
FJ Investments first reported a position in AstraZeneca in Q4 2023 and held it in 1 quarter.
FJ Investments's AstraZeneca position peaked at $1.46M in Q4 2023.
1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on FJ Investments's 13F filing for Q1 2024, filed 15 May 2024.